Respiratory Medicine
Volume 101, Issue 10 , Pages 2207-2212 , October 2007

Occupational exposure and severe pulmonary fibrosis

  • Torbjörn Gustafson

      Affiliations

    • Department of Medicine, Skellefteå Hospital, SE-931 86 Skellefteå, Sweden
    • Corresponding Author InformationCorresponding author. Tel.: +46910771000; fax: +46910771231.
    • ,
  • Anna Dahlman-Höglund

      Affiliations

    • Department of Occupational Medicine, Sahlgrenska University Hospital, SE-413 45 Göteborg, Sweden
    • ,
  • Kenneth Nilsson

      Affiliations

    • Department of Respiratory Medicine and Allergology, Umeå University, SE-901 85 Umeå, Sweden
    • ,
  • Kerstin Ström

      Affiliations

    • Department of Respiratory Medicine, Blekinge Hospital, SE-371 85 Karlskrona, Sweden
    • ,
  • Göran Tornling

      Affiliations

    • Department of Medicine, Division of Respiratory Medicine, Karolinska Institutet, SE-171 77 Stockholm, Sweden
    • ,
  • Kjell Torén

      Affiliations

    • Department of Occupational Medicine, Sahlgrenska University Hospital, SE-413 45 Göteborg, Sweden
    • Department of Lung Medicine and Allergology, Sahlgrenska University Hospital, SE-413 45 Göteborg, Sweden

Received 23 June 2006 ,Accepted 1 February 2007.

References 

  1. Johnston I, Britton J, Kinnear W, Logan R. Rising mortality from cryptogenic fibrosing alveolitis. Br Med J. 1990;301:1017–1021
  2. Hubbard R, Johnston I, Coultas DB, Britton J. Mortality rates from cryptogenic fibrosing alveolitis in seven countries. Thorax. 1996;51:711–716
  3. Mannino DM, Etzel RA, Parrish RG. Pulmonary fibrosis deaths in the United States, 1979–1991. An analysis of multiple-cause mortality data. Am J Respir Crit Care Med. 1996;153:1548–1552
  4. Strom K, Boman G. Long-term oxygen therapy in parenchymal lung diseases: an analysis of survival. The Swedish Society of Chest Medicine. Eur Respir J. 1993;6:1264–1270
  5. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med. 2002;165:277–304
  6. Du Bois RM, Wells AU. Cryptogenic fibrosing alveolitis/idiopathic pulmonary fibrosis. Eur Respir J Suppl. 2001;32:43S–55S
  7. Monso E, Tura JM, Marsal M, Morell F, Pujadas J, Morera J. Mineralogical microanalysis of idiopathic pulmonary fibrosis. Arch Environ Health. 1990;45:185–188
  8. Churg A, Wright JL. Airway wall remodeling induced by occupational mineral dusts and air pollutant particles. Chest. 2002;122:306S–309S
  9. Scott J, Johnston I, Britton J. What causes cryptogenic fibrosing alveolitis? A case–control study of environmental exposure to dust. Br Med J. 1990;301:1015–1017
  10. Iwai K, Mori T, Yamada N, Yamaguchi M, Hosoda Y. Idiopathic pulmonary fibrosis. Epidemiologic approaches to occupational exposure. Am J Respir Crit Care Med. 1994;150:670–675
  11. Hubbard R, Lewis S, Richards K, Johnston I, Britton J. Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis. Lancet. 1996;347:284–289
  12. Baumgartner KB, Samet JM, Coultas DB, et al. Occupational and environmental risk factors for idiopathic pulmonary fibrosis: a multicenter case–control study. Am J Epidemiol. 2000;152:307–315
  13. Miyake Y, Sasaki S, Yokoyama T, et al. Occupational and environmental factors and idiopathic pulmonary fibrosis in Japan. Ann Occup Hyg. 2005;49:259–262
  14. Harris JM, Cullinan P, McDonald JC. Occupational distribution and geographic clustering of deaths certified to be cryptogenic fibrosing alveolitis in England and Wales. Chest. 2001;119:428–433
  15. Hubbard R, Cooper M, Antoniak M, et al. Risk of cryptogenic fibrosing alveolitis in metal workers. Lancet. 2000;355:466–467
  16. Baumgartner KB, Samet JM, Stidley CA, Colby TV, Waldron JA. Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1997;155:242–248
  17. Strom K, Boe J. A national register for long-term oxygen therapy in chronic hypoxia: preliminary results. Eur Respir J. 1988;1:952–958
  18. Toren K, Jarvholm B, Brisman J, Hagberg S, Hermansson BA, Lillienberg L. Adult-onset asthma and occupational exposures. Scand J Work Environ Health. 1999;25:430–435
  19. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Car Med. 2000;161:646–664
  20. Miettinen O. Estimability and estimation in case-referent studies. Am J Epidemiol. 1976;103:226–235
  21. American Thoracic Society. American Thoracic Society Statement: occupational contribution to the burden of airway disease. Am J Respir Crit Care Med. 2003;167:787–797
  22. Fritschi L, Siemiatycki J, Richardson L. Self-assessed versus expert-assessed occupational exposures. Am J Epidemiol. 1996;144:521–527
  23. Bakke PS, Hanoa R, Gulsvik A. Relation of occupational exposure to respiratory symptoms and asthma in a general population sample: self-reported versus interview-based exposure data. Am J Epidemiol. 2001;154:477–483
  24. Flegal KM, Brownie C, Haas JD. The effects of exposure misclassification on estimates of relative risk. Am J Epidemiol. 1986;123:736–751
  25. Sunyer J, Zock JP, Kromhout H, et al. for the for the Occupational Group of the European Community Respiratory Health Survey Lung function decline, chronic bronchitis, and occupational exposures in young adults. Am J Respir Crit Care Med. 2005;172:1139–1145

PII: S0954-6111(07)00220-X

doi: 10.1016/j.rmed.2007.02.027

Respiratory Medicine
Volume 101, Issue 10 , Pages 2207-2212 , October 2007

Article Tools

* Image Usage & Resolution